13-14 March 2008, the scientific and practical conference “Bronchial obstructive diseases and bronchial pulmonary infections: problems and possible ways of solution” took place.

Megacom company participated in pharmaceutical exhibition with Cefutil, Cefodox, Aerofylline and Trifed expectorant preparations.

Conference included Doctor of medicine, professor of internal diseases and general practice of family medicine department in DGMU named after M. Gorkiy, Bagriy Andriy’s report.

Report was devoted to use of methylxanthines in bronchial asthma therapy.

In his report Bagriy Andriy informed of nowadays position of methylxanthines, which is conditioned by our country orders, and also acquainted guests with new methylxanthin – doxofylline.

He shared his own observations while Aerofylline use and drew attention to the fact, that besides having the same clinical efficacy as theophylline, it possesses less side effects.

Present in auditory doctors agreed with him. In the end of the report the resume that doxofylline can be used more widely due to its safety was made.